Environment vs. Genes

Unlike the chicken-and-egg dilemma, scientists know that genes come before the environment. In genetically based diseases, however, the question is not when but how. How do environmental conditions and lifestyle choices interact with a person's molecular structure? "We're all groping in the dark to find out how to get a handle on this complexity," says Marianne Berwick, an epidemiologist at Memorial Sloan-Kettering Cancer Center, New York. Although scientists can now assess exposure levels to

Written byArielle Emmett
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Although scientists can now assess exposure levels to toxic agents and examine the body's response to those toxins through the presence of DNA variations known as biomarkers, finding the trigger point, or points, for disease onset is far more difficult. "Pure, genetically caused disease represents five to 10 percent of the disease burden in the United States; the rest is linked to a combination of multiple factors, both genetic and environmental," says Samuel Wilson, deputy department head, National Institute of Environmental Health Sciences (NIEHS). "Nutrition and lifestyle are huge factors, so we're trying to understand the linkages, including nutrition and lifestyle, in the context of molecular events occurring in cells that lead to the tissue changes characteristic of disease."

The environment-gene link is especially true with cancer. "The overwhelming evidence is that the environment is involved in the vast majority of cancers," says Neil Caporaso, a physician and chief of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies